Trials / Completed
CompletedNCT00199160
Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Jules Bordet Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase II trial evaluating the efficacy and the biological activity of BAY 43-9006 in patients with recurrent and/or metastatic head and neck cancer.
Detailed description
This is a Phase II trial evaluating the efficacy and the biological activity of BAY 43-9006 in patients with recurrent and/or metastatic head and neck cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BAY 43-9006 |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2005-09-20
- Last updated
- 2015-05-20
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00199160. Inclusion in this directory is not an endorsement.